Influence of age at infection on human immunodeficiency virus disease progression to different clinical endpoints: The SEROCO cohort (1988-1994)

International Journal of Epidemiology

Volumn 26, Issue 6, 1997, Pages 1340-1345

  Belanger, F ^a   Meyer, L ^a   Carre N ^a   Coutellier, A ^b   Deveau, C ^a   Rouzioux, C ^c   Bary, M ^c   Burgard, M ^c   Dellamonica, P ^d   Durant, J ^d   Gallais, H ^e   Mars, M E ^e   Gallais, J ^e   Delfraissy, J F ^f   Lebras, P ^f   Goujard, C ^f   Ranon, M ^f   Lefrere J J ^g   Lerable, J ^g   Joubert, L ^g   Cassuto, J P ^h   Quaranta, M ^h   Dupont, B ⁱ   Beuzelin, C ⁱ   Eliaszewicz, M ⁱ   Vittecoq, D ^j   Bolliot, C ^j   Herson, S ^b   Mignon, M ^b   Gastaut, J A ^k   Dhiver, C ^k   Drogoul, M P ^k   Galanaud, P ^l   Boue F ^l   Levy A ^l   Sereni D ^m   Krulick, J ^m   Vilde J L ⁿ   Leport, C ⁿ   Colassante, U ⁿ   Katlama, C ^b   Brucker, G ^b   Richard, M ^b   Sobel, A ^o   Duval, J ^o   Majerholc, C ^o   Desforges, L ^o   Kazatchkine, M ^p   Buisson, M ^p   Guillevin, L ^q   Jarousse, B ^q   Genereau, T ^q   more..

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ACCTES   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

^f BICÊTRE HOSPITAL   (France)

^g INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^h University of Côte d'Azur   (France)

ⁱ INSTITUT PASTEUR   (France)

^j HÔPITAL PAUL BROUSSE   (France)

^k HÔPITAL SAINTE MARGUERITE   (France)

^l HÔPITAL ANTOINE BÉCLÈRE   (France)

^m Hop Antoine Béclère ^*

ⁿ BICHAT HOSPITAL   (France)

^o HENRI MONDOR HOSPITAL   (France)

^p HÔPITAL BROUSSAIS   (France)

^q AVICENNE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELL COUNT; COHORT ANALYSIS; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SURVIVAL;

EID: 17144474647     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/26.6.1340     Document Type: Article

References (23)

1. Fessel W J. Invited commentary: Early symptoms of human immunodeficiency virus infection. Arn J Epidemiol 1995; 141:405-06.
2. Anonymous. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1992; 41 (RR-17): 1-19.
3. Tindall B, Cooper D A. Primary HIV infection: host responses and intervention strategies. AIDS 1991; 5: 1-14.
4. Boufassa F, Bachmeyer C, Carré N et al. Influence of neurologic manifestations of primary Human Immunodeficiency Virus infection on disease progression. J Infect Dis 1995; 171: 1190-95.
5. Carré N, Deveau C, Belanger F et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994; 8: 797-802.
6. Rosenberg P S, Goedert J J, Biggar R J, for the MHCS and the IRS. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994; 8: 803-10.
7. Blaxhult A, Granath F, Lidman K, Giesecke J. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 1990; 4: 125-29.
8. Phillips A N, Lee C A, Elford J et al. More rapid progression to AIDS in older HIV infected people: the role of CD4+ T-Cell counts. J Acquir Immune Defic Syndr 1991; 4: 970-75.
9. Veugelers P J, Page K A, Tindall B et al. Determinants of HIV disease progression among homosexual men registered in the tricontinental seroconverter study. Am J Epidemiol 1994; 140: 747-58.
10. Hessol N A, Koblin B A, van Griesven G P et al. Progression of Human Immunodeficiency Virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York city, and San Francisco, 1978-1991. Am J Epidemiol 1994; 139: 1077-87.
11. Anonymous. Markers as time-dependent covariat.es in relative risk regression. Map Workshop (Multi-cohort Analysis Project). Stat Med 1993; 12: 2087-98.
12. Weinberg K, Parkman R. Age, thymus, and T lymphocytes. N Engl J Med 1995; 332: 182-83.
13. Gardner I D. The effect of age on susceptibility to infection. Rev Infect Dis 1980; 2: 801-10.
14. Saltzman R L, Peterson P K. Immunodeficiency of the elderly. Rev Infect Dis 1987; 9: 1127-39.
15. Longini I M, Clark W S, Gardner L I, Brundage J F. The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. J Acquir Immune Defic Syndr 1991; 4: 1141-47.
16. Anonymous. Concorde: MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee. Lancet 1994; 343 (8902): 871-81.
17. Bucquet D, Deveau C, Belanger F et al. Multicenter French cohort of adults with HIV infection. Description and course after 4 years follow-up. Presse Med (In French), 1994; 23: 1247-51.
18. Cox D R. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187-220.
19. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford Science Publications. Oxford: Oxford University Press, 1994, pp. 249-72.
20. Hosmer D W, Lemeshow S. Applied Logistic Regression. Wiley series in probability and mathematical statistics. New York: John Wiley and Sons, 1989, pp. 83-91.
21. Kalbfleish J D, Prentice R L. The Statistical Analysis of Failure Time Data. Wiley series in probability and mathematical statistics. New York: John Wiley and Sons, 1980, pp. 87-89.
22. Brookmeyer R, Gail M H, Polk B F. The prevalent cohort study and the acquired immunodeficiency syndrome. Am J Epidemiol 1987; 126: 14-24.
23. Goedert J J, Kessler C M, Aledort L M et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321: 1141-48.